marketcap
Facebook
Twitter
Telegram
Fehler meldenQuartalsbericht 2024-Q3
hinzugefügt 07.11.2024
Allogene Therapeutics Bilanz 2011-2024 | ALLO
Bilanz Jährlich Allogene Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
12 M | 39.2 M | -100 M | -139 M | -124 M | -58 M | - | - | - | - | - | - | - |
Langfristige Schulden |
88.3 M | 95.1 M | 69.9 M | 50.8 M | - | - | - | - | - | - | - | - | - |
Langfristiger Schuldenstrom |
6.78 M | 6 M | 3.2 M | 2.97 M | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | 55.7 M | 41.2 M | - | - | - | - | - | - | - |
Kurzfristige Verbindlichkeiten |
37.1 M | 53.7 M | 47.9 M | 94.3 M | 33.1 M | 29.5 M | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
131 M | 155 M | 126 M | 148 M | 88.8 M | 70.7 M | 2 K | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
86 K | 95 K | 156 K | 39 M | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-1.56 B | -1.23 B | -895 M | -713 M | -396 M | -212 M | -23 K | - | - | - | - | - | - |
Vermögenswerte |
643 M | 822 M | 1.05 B | 1.23 B | 718 M | 774 M | - | - | - | - | - | - | - |
Zahlungsmittel |
83.2 M | 61.9 M | 173 M | 193 M | 175 M | 92.4 M | - | - | - | - | - | - | - |
Buchwert |
512 M | 667 M | 925 M | 1.08 B | 629 M | 703 M | -2 K | - | - | - | - | - | - |
Gesamtes Eigenkapital |
512 M | 667 M | 925 M | 1.01 B | 629 M | 703 M | -2 K | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Bilanz Vierteljährlich Allogene Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
85.1 M | 87 M | 88.9 M | 88.3 M | 90.1 M | 91.8 M | 93.5 M | 95.1 M | 96.7 M | 98.2 M | 69 M | 69.9 M | 50.6 M | 51.2 M | 51.6 M | 50.8 M | 50.8 M | 50.8 M | 50.8 M | 51.3 M | 51.3 M | 51.3 M | 51.3 M | 34.5 M | 34.5 M | 34.5 M | 34.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
125 M | 132 M | 125 M | 131 M | 129 M | 148 M | 155 M | 151 M | 148 M | 146 M | 109 M | 122 M | 109 M | 103 M | 109 M | 148 M | 148 M | 148 M | 148 M | 88.8 M | 88.8 M | 88.8 M | 88.8 M | 70.7 M | 70.7 M | 70.7 M | 70.7 M | 2 K | 2 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | 86 K | 86 K | 236 K | 229 K | 273 K | 885 K | 889 K | 836 K | 406 K | 423 K | 365 K | 305 K | 239 K | 39 M | 39 M | 39 M | 39 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-1.76 B | -1.69 B | -1.63 B | -1.56 B | -1.47 B | -1.41 B | -1.33 B | -1.24 B | -1.14 B | -1.06 B | -983 M | -903 M | -828 M | -750 M | -679 M | -646 M | -646 M | -646 M | -646 M | -396 M | -396 M | -396 M | -396 M | -212 M | -212 M | -212 M | -212 M | -23 K | -23 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
589 M | 647 M | 586 M | 643 M | 712 M | 771 M | 747 M | 817 M | 888 M | 948 M | 965 M | 1.04 B | 1.08 B | 1.13 B | 1.18 B | 1.23 B | 1.23 B | 1.23 B | 1.23 B | 718 M | 718 M | 718 M | 718 M | 774 M | 774 M | 774 M | 774 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zahlungsmittel |
51.2 M | 171 M | 51 M | 83.2 M | 79.5 M | 165 M | 120 M | 61.9 M | 84.6 M | 106 M | 94.8 M | 173 M | 199 M | 233 M | 237 M | 193 M | 183 M | 183 M | 183 M | 175 M | 175 M | 175 M | 175 M | 92.4 M | 92.4 M | 92.4 M | 92.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Buchwert |
464 M | 515 M | 461 M | 512 M | 583 M | 623 M | 592 M | 666 M | 740 M | 802 M | 855 M | 916 M | 970 M | 1.02 B | 1.07 B | 1.08 B | 1.08 B | 1.08 B | 1.08 B | 629 M | 629 M | 629 M | 629 M | 703 M | 703 M | 703 M | 703 M | -2 K | -2 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
464 M | 515 M | 461 M | 512 M | 581 M | 621 M | 592 M | 666 M | 740 M | 802 M | 855 M | 916 M | 970 M | 1.02 B | 1.07 B | 1.08 B | 1.08 B | 1.08 B | 1.08 B | 629 M | 629 M | 629 M | 629 M | 703 M | 703 M | 703 M | 703 M | -2 K | -2 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung